Form 10-Q Pacira BioSciences, Inc. For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Form 10-Q Pacira BioSciences, Inc. For: Jun 30

Pacira Pharmaceuticals (PCRX) PT Lowered to $30 at Jefferies

August 1, 2024 3:59 PM EDT

Jefferies analyst Glen Santangelo lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $30.00 (from $36.00) while maintaining a Buy rating.

The analyst comments "Updating model to reflect 2Q results. Overall, we think NT results remain overshadowed by the pending court ruling... More

Pacira Pharmaceuticals (PCRX) PT Lowered to $37 at RBC Capital

July 31, 2024 6:24 AM EDT

RBC Capital analyst Daniel Busb lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $37.00 (from $42.00) while maintaining a Outperform rating.

The analyst comments "While PCRX continues to execute on delivering positive Exparel numbers through 1H, focus remains squarely on ongoing patent... More